NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
// Chao Zhang 1, 2 , Hui-Jie Wang 1, 2 , Qi-Chao Bao 1, 2 , Lei Wang 1, 2 , Tian-Kun Guo 1, 2 , Wei-Lin Chen 1, 2 , Li-Li Xu 1, 2 , Hai-Shan Zhou 1, 2 , Jin-Lei Bian 1, 2 , Ying-Rui Yang 1, 2 , Hao-Peng Sun 1, 2, 3 , Xiao-Li Xu 1, 2, 3 , Qi-Dong You 1, 2, 3 1 Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China 2 State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, China 3 Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China Correspondence to: Xiao-Li Xu, email: xuxiao_li@126.com Qi-Dong You, email: youqidong@gmail.com Keywords: NRF2, breast cancer, RhoA/ROCK pathway, cell proliferation, metastasis Received: January 04, 2016 Accepted: September 26, 2016 Published: October 04, 2016 ABSTRACT Nuclear factor erythroid 2-related factor (NRF2) is an important transcription factor in oxidative stress regulation. Overexpression of NRF2 is associated with human breast carcinogenesis, and increased NRF2 mRNA levels predict poor patient outcome for breast cancer. However, the mechanisms linking gain of NRF2 expression and poor prognosis in breast cancer are still unclear. Here, we provide evidence that NRF2 deletion inhibits proliferation and metastasis of breast cancer cells by down-regulating RhoA. Restoration of RhoA in MCF7 and MDA-MB-231 cells induced NRF2 knockdown-suppressed cell growth and metastasis in vitro, and NRF2 silencing suppressed stress fiber and focal adhesion formation leading to decreased cell migration and invasion. Mechanistic studies showed that NRF2 binds to the promoter region of estrogen-related receptor α (ERR1) and may function as a silencer. This may enhance RhoA protein stability and lead to RhoA overexpression in breast cancer cell. Our findings indicate that NRF2 silencing-mediated reduction of RhoA expression contributes, at least in part, to the poor outcome of breast cancer patients with high NRF2 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
RHO GTPASES: Biochemistry and Biology
Jaffe, A. B., & Hall, A. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.020604.150721 · Cited by 3,009 · cited 1×
“Members of the Rho family of GTPases play key roles in cytoskeletal reprogramming by acting as molecular switches that control morphogenesis and movement [15].”
BackgroundOncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277 · cited 1×
“However, other studies have shown that NRF2 is aberrantly activated in various breast cancer cells [8–11], and more recent genetic studies of human breast tumors have indicated NRF2 that plays a crucial role in oncogenesis [12, 13].”
BackgroundROCKs: multifunctional kinases in cell behaviour
Riento, K., & Ridley, A. J. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1128 · Cited by 1,941
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.016 · Cited by 1,395 · cited 1×
“For instance, NRF2 overexpression has been reported to enhance cell growth of lung cancer by increasing metabolism through the PI3K/Akt pathway [39].”
BackgroundA mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity
Nioi, P., & Nguyen, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.051 · Cited by 212
Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis
Chan, C.-H., Lee, S.-W., Li, C.-F., Wang, J., Yang, W.-L., Wu, C.-Y., Wu, J., Nakayama, K. I., Kang, H.-Y., Huang, H.-Y., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2047 · Cited by 209 · cited 1×
“Aberrantly high expression of RhoA is thought to be a trigger of breast tumor proliferation and metastasis [27].”
Background
Cited by
NRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672
Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer
Bae, T., Hallis, S. P., & Kwak, M.-K. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01180-8 · Cited by 354
The Role of Nrf2 Activity in Cancer Development and Progression
Zimta, A.-A., Cenariu, D., Irimie, A., Magdo, L., Nabavi, S. M., Atanasov, A. G., & Berindan-Neagoe, I. (2019) · Cancers · doi:10.3390/cancers11111755 · Cited by 292
Antioxidants: Positive or Negative Actors?
Salehi, B., Martorell, M., Arbiser, J., Sureda, A., Martins, N., Maurya, P., Sharifi-Rad, M., Kumar, P., & Sharifi-Rad, J. (2018) · Biomolecules · doi:10.3390/biom8040124 · Cited by 255
Involvement of NRF2 in Breast Cancer and Possible Therapeutical Role of Polyphenols and Melatonin
Tascioglu Aliyev, A., Panieri, E., Stepanić, V., Gurer-Orhan, H., & Saso, L. (2021) · Molecules · doi:10.3390/molecules26071853 · Cited by 50
Metadata
- Authors
- Zhang, C., Wang, H.-J., Bao, Q.-C., Wang, L., Guo, T.-K., Chen, W.-L., Xu, L.-L., Zhou, H.-S., Bian, J.-L., Yang, Y.-R., Sun, H.-P., Xu, X.-L., & You, Q.-D.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-10-04
- Volume
- 7
- Issue
- 45
- Pages
- 73593-73606
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2528036599
- Cited by
- 127
- References
- 7
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction. https://app.cochat.ai/papers/10.18632/oncotarget.12435
- The paper
- Zhang, C., Wang, H.-J., Bao, Q.-C., Wang, L., Guo, T.-K., Chen, W.-L., Xu, L.-L., Zhou, H.-S., Bian, J.-L., Yang, Y.-R., Sun, H.-P., Xu, X.-L., & You, Q.-D. (2016). NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction. Oncotarget. https://doi.org/10.18632/oncotarget.12435
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.